You are here

Europe

'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops

Endpoints

Wed, 06/19/19 - 10:29 am

Bristol-Myers Squibb

AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment

Yahoo/Reuters

Tue, 06/18/19 - 10:04 am

Bluebird sets $1.8M price tag for blood-disease gene therapy

Biopharma Dive

Fri, 06/14/19 - 12:08 pm

beta thalassemia

5 Things You'll Want to Watch With GW Pharmaceuticals

Motley Fool

Wed, 06/12/19 - 09:41 am

Germany's Stada buys six of GSK's consumer brands, eyes further deals

Yahoo/Reuters

Fri, 06/7/19 - 10:10 am

consumer health

Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval

Xconomy

Mon, 06/3/19 - 07:50 pm

beta thalassemia

EMA imposes formal limit on Xeljanz prescription as regulators continue to review safety concerns

Endpoints

Sat, 05/18/19 - 08:47 pm

post-marketing studies

EU universities are miserably lax at reporting clinical trial results, analysis suggests

Endpoints

Mon, 04/29/19 - 09:41 pm

clinical trial data

clinical trials

Lynparza on cusp of EU approval for advanced ovarian cancer

Pharmaforum

Mon, 04/29/19 - 10:28 am

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

Pharmaforum

Wed, 04/10/19 - 09:46 am

BRCA-mutant breast cancer

After falling short on prelim OS data, EMA tells Aveo it wants to see something better on its long suffering tivo this summer — or else

Endpoints

Wed, 04/3/19 - 10:03 am

Teva wins EU nod for Ajovy migraine prophylactic

Drug Delivery Business News

Tue, 04/2/19 - 04:25 pm

Teva Pharmaceutical

AbbVie's massive Humira discounts are stifling Netherlands biosimilars: report

Fierce Pharma

Tue, 04/2/19 - 12:09 pm

First gene therapy to treat rare blood disease nears European approval

Stat

Fri, 03/29/19 - 10:05 am

beta-thalassemia

Drug Sampling and Testing: EMA Releases 20 Year Report, Will Expand Program to Biosimilars

RAPS.org

Thu, 03/28/19 - 07:45 pm

As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?

Pharmaforum

Thu, 03/28/19 - 10:13 am

Sanofi may airlift medicines into UK after Brexit

Pharmaforum

Tue, 03/26/19 - 09:52 am

Aimmune's peanut allergy immunotherapy clears European PhIII with flying colors, paving way for first US, EU therapeutic approval

Endpoints

Mon, 03/25/19 - 12:03 pm

AZ’s diabetes drug Forxiga approved in EU for type 1 disease

Pharmaforum

Mon, 03/25/19 - 10:17 am

type 1 diabetes diabetes

Brexit delay offers biopharma more time to prepare for a no-deal

BioCentury

Fri, 03/22/19 - 10:14 pm

Pages